PE-Backed Acacium Group Acquires SUMO Medical Staffing
Acacium Group, backed by private equity firm Onex Corp., announced on September 8 that it acquired Sumo Medical Staffing for an undisclosed price. Headquartered in Draper, Utah, SUMO Medical Staffing is a locum tenens agency dedicated to placing qualified physicians and advanced practice providers in temporary and permanent positions across the United States. The company places medical professionals in specialties including psychiatry, internal medicine, hospitalist, family medicine, ER/urgent care and pediatrics. Acacium Group is one of the United Kingdom’s largest healthcare workforce solutions and services partner dedicated to offering staffing, managed services and... Read More »
Havencrest Announces Majority Investment in Tekton Research
Dallas-based Havencrest Capital Management has announced a majority investment in Tekton Research, LLC. According to data captured in the LevinPro HC database, this transaction represents the 25th clinical trials acquisition of 2023. Founded in 2006 and headquartered in Austin, Texas, Tekton Research is a clinical trial site network with 23 sites across Texas, Colorado, Georgia, Kansas and Oklahoma. Tekton conducts clinical trials across several therapeutic areas, including vaccines and infectious disease, neurology, endocrinology, immunology and dermatology, among others. Havencrest is a committed capital, lower middle-market private equity investment firm focused exclusively... Read More »
NextGen Healthcare Inks $1.6 Billion Sale to PE Firm Thoma Bravo
Private equity group Thoma Bravo has entered into an agreement to acquire NextGen Healthcare, Inc. for approximately $1.61 billion. Under the terms of the agreement, NextGen Healthcare shareholders will receive $23.95 per share in cash. NextGen Healthcare is an American software and services company headquartered in Atlanta, Georgia. The company develops and sells electronic health record (EHR) software and practice management systems to the healthcare industry. According to its most recent financial report, the company’s revenue for the fiscal year ended March 31, 2022 was $596.4 million. Thoma Bravo is a leading private equity investment firm building on a 30-plus year... Read More »
Cerba HealthCare Acquires Canadian CRO Cirion BioPharma Research
Cerba HealthCare announced on September 7 that it has acquired Cirion BioPharma Research, a contract research organization (CRO) in Laval, Quebec. Cirion BioPharma Research is a Canadian contract research laboratory providing global central laboratory services for clinical studies and research and development services. Cerba Healthcare is a leader in clinical pathology specializing in local clinical pathology, specialized clinical pathology and central lab testing for clinical trials. Its shareholders include Partners Group and the Public Sector Pension Investment Boards. Cirion will rank under Cerba HealthCare’s business unit Cerba Research adding to its global network of... Read More »
